Despite Increased Ownership, Glenview Capital Doesn't Intend to Acquire HMA

Last week, the board of Naples, Fla.-based Health Management Associates ratified a shareholder rights plan to protect itself from its largest shareholder, New York City-based hedge fund Glenview Capital Management, but Glenview Capital executives do not expect to take over the for-profit hospital company, according to Dow Jones report.

A shareholder rights plan, known in the business world as a "poison pill," is a tactic used by publicly held companies to protect themselves from a possible takeover of a large shareholder. In a May 6 filing, Glenview announced it owned approximately 37.8 million shares, or 14.6 percent, of Health Management's stock. In addition, Glenview said it may increase its ownership of Health Management even further, which could potentially result in a takeover.

Under Health Management's one-year shareholder rights plan, other shareholders would be protected from any possible takeover by Glenview if the hedge fund's ownership stake reaches 15 percent or higher. Health Management executives said it adopted the plan to "help promote fair and equal treatment of all stockholders of the corporation (not just Glenview) and ensures that the board of directors remains in the best position to discharge its fiduciary duties."

According to the Dow Jones report, Glenview executives clarified that "Glenview has made no proposals, either to HMA or to any of its holdings over a 13-year period, which are to the exclusive benefit of Glenview."

More Articles on Health Management Associates:

For-Profit Hospital Stock Report: Week of May 20-24, 2013
9 Major For-Profit Hospital Companies Post $527M in Quarterly Profits
HMA, Florida Blue Strike Accountable Care Deal

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers